SEC Form 4 · accession 0001127602-17-018094
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geno J Germano
Director
Period of report
May 11, 2017
Accepted (ET)
May 15, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1 | $55.04 | May 11, 2017 | A | 21,729 | A | — | May 11, 2027 | Common Stock | 21,729 | 21,729 | D |
Explanation of responses
- F1This option vests in three equal annual installments beginning on May 11, 2018.